# FDA Inspection 1225603 - Exelead, Inc. - December 20, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/exelead-inc/f8900203-7a73-476a-a795-450d85e7698c/
Source feed: FDA_Inspections

> FDA Inspection 1225603 for Exelead, Inc. on December 20, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225603
- Company Name: Exelead, Inc.
- Inspection Date: 2023-12-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287394 - 2025-09-04](https://www.globalkeysolutions.net/api/records/fda_inspections/exelead-inc/b76fee43-2eb7-4835-bc04-9bfa723f193f/)
- [FDA Inspection 1287394 - 2025-09-04](https://www.globalkeysolutions.net/api/records/fda_inspections/exelead-inc/2a2ae040-8e2c-486a-b58d-3ec609859b61/)
- [FDA Inspection 1062147 - 2018-07-30](https://www.globalkeysolutions.net/api/records/fda_inspections/exelead-inc/298996cf-5e07-4e18-b422-dc7ad5b46486/)
- [FDA Inspection 922118 - 2015-04-10](https://www.globalkeysolutions.net/api/records/fda_inspections/exelead-inc/7d7fcaf6-d5bd-4142-8bd6-d14c7a28fcba/)
- [FDA Inspection 878732 - 2014-05-16](https://www.globalkeysolutions.net/api/records/fda_inspections/exelead-inc/e1f99faa-c598-4729-a130-fe9fb751ddce/)

Company: https://www.globalkeysolutions.net/companies/exelead-inc/ca24adb3-36c5-4253-a831-dc2328d3c9d7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c